| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V1087 | ADX-47273 (BA 94673139) | 851881-60-2 | ADX47273 (ADX-47273;BA-94673139;BA94673139)is a potent, selectiveand specific mGlu5 positive allosteric modulator(PAM) with important biological activity. |
|
V33762 | CNQX | 115066-14-3 | CNQX (FG9065; FG-9065; 6-cyano-7-nitroquinoxaline-2,3-dione)is an AMPA/kainate antagonist that inhibits AMPA and kainate receptors with IC50values of 0.3 μM, 1.5 μM, respectively. |
|
V1084 | CTEP (RO4956371) | 871362-31-1 | CTEP (also called RO4956371; RO 4956371;RO-4956371) is a long-acting and orally bioavailable allosteric antagonist of metabotropic glutamate receptor 5 (mGlu5) receptor with important biological activity. |
|
V1982 | D-glutamine | 5959-95-5 | D-glutamine (also known as H-D-Gln-OH), an unnatural isomer of glutamine, is a D type stereoisomer of glutamine which is one of the 20 amino acids encoded by the standard genetic code. |
|
V11432 | AP-5 | 76326-31-3 | AP-5 (AP5) is a novel, selective and potent NMDA (N-methyl-D-aspartate) receptor antagonist with anticonvulsant activity. |
|
V2710 | Evans Blue | 314-13-6 | Evans Blue (Direct Blue 53)is a potent inhibitor of the uptake of L-glutamate into synaptic vesicles, it is also an AMPA/kainate receptor antagonist. |
|
V1088 | IEM 1754 2HBr | 162831-31-4 | IEM 1754 2HBr (IEM-1754; IEM 1754; IEM1754), the dihydrobromide salt ofIEM-1754, is a selective voltage-dependent open-channel blocker of AMPA/kainate receptorswith important biological activity. |
|
V1086 | NMDA (N-Methyl-D-aspartic acid) | 6384-92-5 | NMDA (N-Methyl-D-aspartic acid; LC488A; LC488 A;LC488-A; LC 488A; LC-488A) is an aspartic acid analog withan N-methyl substituent and D-configuration and a glutamate-like excitatory chemical substance. |
|
V1079 | Pomaglumetad (LY404039) | 635318-11-5 | Pomaglumetad (LY404039; LY-404039; LY-404,039; LY404,039) is a novel and potent agonist of recombinant human mGlu2/mGlu3 receptors with the potential for the treatment of Schizophrenia. |
|
V23963 | Ro 25-6981 free base | 169274-78-6 | Ro 25-6981 is a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. |
|
V1090 | VU 0357121 | 433967-28-3 | VU0357121 (VU-0357121, VU 0357121) is a positive allosteric modulator (PAM) of mGlu5 (metabotropic glutamate receptor 4) with antiparkinsonian-like effects. |
|
V1092 | VU 0361737 | 1161205-04-4 | VU 0361737 (VU0361737; VU-0361737) is a novel, brain-penetrable and selective positive allosteric modulator (PAM) for mGlu4 receptor with important biological activity. |
|
V1085 | VU 0364439 | 1246086-78-1 | VU 0364439 (VU0364439; VU-0364439) is a mGlu4 (metabotropic glutamate receptor 4) positive allosteric modulator (PAM) with important biological activity. |
|
V1091 | VU 0364770 | 61350-00-3 | VU 0364770 (VU-0364770, VU0364770) is a potent positive allosteric modulator (PAM) of mGlu4 (metabotropic glutamate receptor 4) with anti-parkinsonian-likeactivity. |
|
V1094 | Piracetam (UCB-6215) | 7491-74-9 | Piracetam (BRN-1526393;UCB-6215; Cl-871;Breinox;Ciclofalina;Euvifor; Gabacet; Nootron)is a cyclized derivative of the neurotransmitter gamma-aminobutyric acid (GABA) that has been approved for use in the treatment of a wide range of cognitive disorders. |
|
V1078 | Riluzole (RP-54274, PK 26124) | 1744-22-5 | Riluzole (formerly PK26124, RP54274, RP-54274, PK-26124;Rilutek),an anticonvulsant of the Na+channelblocker class, is a glutamate release inhibitor with neuroprotective, anticonvulsant, anxiolytic and anesthetic activities. |
|
V1081 | (-)-Dizocilpine Maleate [(-)-MK 801 maleate] | 121917-57-5 | DizocilpineMaleate [also known as (-)-MK-801; MK801; MK 801], the maleate salt ofdizocilpine, is anovel, potent, selective and non-competitiveN-methyl-D-aspartate (NMDA) receptor antagonist with potential to treat awide range of neurodegenerative conditions or disorders in which NMDA receptors play an important role. |
|
V5684 | Dizocilpine (MK-801) | 77086-21-6 | Dizocilpine (MK-801), is a novel, potent, selective and non-competitive NMDA (N-Methyl-D-aspartate) receptor antagonist with Kd of 37.2 nM in rat brain membranes. |
|
V7337 | CX-516 | 154235-83-3 | CX516 (BDP 12) is a positive regulator of AMPA receptors and may be utilized in study/research of Alzheimer's disease (AD), schizophrenia, etc. |
|
V1089 | MPEP | 96206-92-7 | MPEP is a highly potent, selective, and non-competitive antagonist of mGlu5 receptor with anti-anxiolytic/antidepressant activity. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
